Literature DB >> 21225364

Videourodynamics in patients with neurogenic bladder due to multiple sclerosis: our experience.

D Caramella1, G Donatelli, N Armillotta, F Manassero, C Traversi, P Frumento, D Pistolesi, C Selli.   

Abstract

PURPOSE: The aims of this study were to: (a) analyse the most frequent morphofunctional features of the lower urinary tract observed during videourodynamic examination in patients with neurogenic bladder due to multiple sclerosis; (b) investigate the role of the videourodynamic examination in the clinical management of these patients; and (c) demonstrate the relationship between morphological and functional variables.
MATERIALS AND METHODS: We performed videourodynamic examinations in 75 patients affected by neurogenic bladder secondary to multiple sclerosis.
RESULTS: The introduction of pharmacological therapy, based on clinical and functional evaluation of the lower urinary tract, is correlated with satisfactory morphofunctional outcomes, reducing moderate-to-severe postvoid residual (PVR; p < 0.1) and compliance (p < 0.05) at the price of reduced bladder sensation. Clinical management of these patients based on morphological evaluation of the lower urinary tract decreased the occurrence of detrusor-sphincter dyssynergy (DSD) and detrusor overactivity incontinence at the following examination.
CONCLUSIONS: Our study confirmed a relationship between detrusor overactivity and hypertonic bladder, bladder diverticula, vesicoureteral reflux, between detrusor underactivity and PVR and between DSD and bladder diverticula. Our data show how the videourodynamic examination may improve evaluation and urological management of these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225364     DOI: 10.1007/s11547-011-0620-2

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  14 in total

Review 1.  Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies.

Authors:  Ranan DasGupta; Clare J Fowler
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

2.  Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system.

Authors:  M Ukkonen; I Elovaara; P Dastidar; T L J Tammela
Journal:  Acta Neurol Scand       Date:  2004-02       Impact factor: 3.209

Review 3.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

Review 4.  The epidemiology of multiple sclerosis in Europe.

Authors:  M Pugliatti; G Rosati; H Carton; T Riise; J Drulovic; L Vécsei; I Milanov
Journal:  Eur J Neurol       Date:  2006-07       Impact factor: 6.089

5.  Urodynamic pattern changes in multiple sclerosis.

Authors:  S J Ciancio; S E Mutchnik; V M Rivera; T B Boone
Journal:  Urology       Date:  2001-02       Impact factor: 2.649

Review 6.  Multiple sclerosis and the urologist.

Authors:  S E Litwiller; E M Frohman; P E Zimmern
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

7.  Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases.

Authors:  P Gallien; S Robineau; B Nicolas; M P Le Bot; R Brissot; M Verin
Journal:  Arch Phys Med Rehabil       Date:  1998-03       Impact factor: 3.966

8.  EAU guidelines on neurogenic lower urinary tract dysfunction.

Authors:  Manfred Stöhrer; Bertil Blok; David Castro-Diaz; Emanuel Chartier-Kastler; Giulio Del Popolo; Guus Kramer; Jürgen Pannek; Piotr Radziszewski; Jean-Jacques Wyndaele
Journal:  Eur Urol       Date:  2009-04-21       Impact factor: 20.096

Review 9.  The genetic epidemiology of multiple sclerosis.

Authors:  Shannon J Kenealy; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  J Neuroimmunol       Date:  2003-10       Impact factor: 3.478

10.  Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis.

Authors:  E L Koldewijn; O R Hommes; W A Lemmens; F M Debruyne; P E van Kerrebroeck
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

View more
  2 in total

Review 1.  Management of neurogenic bladder in patients with multiple sclerosis.

Authors:  Véronique Phé; Emmanuel Chartier-Kastler; Jalesh N Panicker
Journal:  Nat Rev Urol       Date:  2016-03-31       Impact factor: 14.432

2.  Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.

Authors:  Tao Wang; Wei Huang; Yong Zhang
Journal:  Chin Med J (Engl)       Date:  2016-03-20       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.